query-opentarget

To find top genetic targets for a disease, query the OpenTargets Platform to retrieve associated targets ranked by overall evidence scores. You receive structured responses containing standard Ensembl and EFO identifiers along with datasource breakdowns for programmatic target validation.

Yes, you can retrieve known drugs and mechanism of action for a specific target. Querying the OpenTargets Platform returns drug annotations and clinical phase information alongside target-drug links, supporting drug-target association analysis and literature review workflows.

Target validation evaluates disease-gene associations using heterogeneous data sources. The OpenTargets Platform provides datasource breakdowns for evidence scores, allowing you to inspect the specific genetic, literature, and drug evidence contributing to an overall target-disease association.

To query diseases linked to a gene, search by gene symbol or Ensembl ID to retrieve associated diseases from the OpenTargets Platform. The results provide standard EFO identifiers and evidence scores for programmatic downstream bioinformatics analysis.

Yes, querying the OpenTargets Platform uses GraphQL to return structured responses. These include evidence scores, datasource breakdowns, standard Ensembl and EFO identifiers, and known drug annotations formatted for programmatic downstream analysis.

OpenTargets Platform data for target validation is limited to retrieving and inspecting existing gene-disease associations and drug-target relationships. It provides evidence scores and datasource breakdowns to inform experimental prioritization but does not perform internal predictive modeling.